Personal information

Other IDs

Scopus Author ID: 57196438692

Activities

Collapse all

Employment (2)

Masaryk Memorial Cancer Institute: Brno, CZ

2022 to present | Junior Researcher (RECAMO)
Employment
Source: Self-asserted source
Martin Krkoška

Institute of Biophysics of the Czech Academy of Sciences: Brno, --, CZ

2016 to 2022-06-30 | PhD candidate (Department of Cytokinetics)
Employment
Source: Self-asserted source
Martin Krkoška

Education and qualifications (3)

Masaryk University: Brno, CZ

2016 to 2023 | PhD (Department of Experimental Biology)
Education
Source: Self-asserted source
Martin Krkoška

Masaryk University: Brno, CZ

2016 | MSc (Department of Experimental Biology)
Education
Source: Self-asserted source
Martin Krkoška

Masaryk University: Brno, CZ

2014 | Bc (Department of Experimental Biology)
Education
Source: Self-asserted source
Martin Krkoška

Works (5)

Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma

Pharmacological Reports
2021-11-15 | Journal article
DOI: 10.1007/s43440-021-00338-9
Part of ISSN: 1734-1140
Part of ISSN: 2299-5684
Source: Self-asserted source
Martin Krkoška

Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes

Toxicology
2021-09 | Journal article
DOI: 10.1016/j.tox.2021.152897
Part of ISSN: 0300-483X
Source: Self-asserted source
Martin Krkoška

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors

Toxicological Sciences
2019 | Journal article
DOI: 10.1093/toxsci/kfz202
EID:

2-s2.0-85075812627

Part of ISSN: 10960929 10966080
Contributors: Svobodová, J.; Procházková, J.; Kabátková, M.; Krkoška, M.; Šmerdová, L.; Líbalová, H.; Topinka, J.; Kléma, J.; Kozubík, A.; Machala, M. et al.
Source: Self-asserted source
Martin Krkoška via Scopus - Elsevier

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells

Neoplasia (United States)
2017 | Journal article
DOI: 10.1016/j.neo.2017.08.002
EID:

2-s2.0-85033222892

Part of ISSN: 14765586 15228002
Contributors: Herůdková, J.; Paruch, K.; Khirsariya, P.; Souček, K.; Krkoška, M.; Vondálová Blanářová, O.; Sova, P.; Kozubík, A.; Hyršlová Vaculová, A.
Source: Self-asserted source
Martin Krkoška via Scopus - Elsevier

Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10

PLoS ONE
2017 | Journal article
DOI: 10.1371/journal.pone.0188584
EID:

2-s2.0-85035775065

Part of ISSN: 19326203
Contributors: Blanářová, O.V.; Šafaříková, B.; Herůdková, J.; Krkoška, M.; Tománková, S.; Kahounová, Z.; Anděra, L.; Bouchal, J.; Kharaishvili, G.; Král, M. et al.
Source: Self-asserted source
Martin Krkoška via Scopus - Elsevier
How many people are using ORCID?